<DOC>
	<DOCNO>NCT00536172</DOCNO>
	<brief_summary>This study evaluate effectiveness escitalopram prevent depression head neck cancer patient receive treatment .</brief_summary>
	<brief_title>Evaluating Effectiveness Escitalopram Prevent Depression Head Neck Cancer Patients Receiving Treatment</brief_title>
	<detailed_description>Most type head neck cancer develop line cell find within many part head neck . Each year , 40,000 adult diagnose head neck cancer United States . The lead cause type cancer tobacco use . Common sign symptom head neck cancer include blood saliva ; frequent nose bleeds ; difficulty chewing , swallow , breathe . Effective treatment head neck cancer available cancer find early stage . However , treatment difficult , cause many people become depressed within 3 month diagnose . Unfortunately , depression lead delay treatment , impair quality life , decrease long-term survival . The purpose study determine whether use antidepressant medication initiate prior start treatment prevent onset depression treatment non-depressed head neck cancer patient . This study also determine escitalopram maintain quality life treatment , improve participation treatment , decrease delay premature discontinuation treatment , reduce alcohol tobacco use patient head neck cancer . All participant attend initial screening , follow eight clinic visit . The first clinic visit include completion interview brief questionnaires regard depression , mental emotional health , alcohol tobacco use , quality life . Participants randomly assign receive 16 week antidepressant escitalopram placebo pill . Participants take 10 mg assign medication every day first week 20 mg assign medication every day remain 15 week . Participants visit clinic every 2 week treatment , time answer question similar ask initial visit . Any medication side effect also record visit . Once treatment complete , participant visit clinic three time period 12 week . Similar question treatment visit ask . Results study use assess whether depression preventable head neck cancer patient antidepressant medication initiate treatment begin .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Newly diagnose recurrent epidermoid cancer head neck Requires minimal therapy treatment Able read write English Willing use effective form birth control throughout study Meets MINI criterion major depression , schizophrenia , bipolar illness score 24 less Suicidal psychotic Current allergy hypersensitivity citalopram SSRIs Treated monoamine oxidase inhibitor 14 day prior study entry Use antidepressant within 1 week study entry Pregnant breastfeed History adequate cancer operation , radiation , chemotherapy within 6 month study entry Diagnosed melanoma lymphoma cancer head neck Currently participate another research study involve therapeutic intervention</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Antidepressant</keyword>
	<keyword>Major depression</keyword>
	<keyword>Prevention</keyword>
	<keyword>Head neck cancer</keyword>
</DOC>